Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Reproductive issues in women with multiple sclerosis: ethical considerations.
In vivo evidence of glutamate toxicity in multiple sclerosis.
Corticosteroids for treating optic neuritis.
New Disease-Modifying Therapies and New Challenges for MS.
Incidental MRI anomalies suggestive of multiple sclerosis: the radiologically isolated syndrome.
QualiCOP: real-world effectiveness, tolerability, and quality of life in patients with relapsing-remitting multiple sclerosis treated with glatiramer acetate, treatment-naïve patients, and previously treated patients.
Correlates of Executive Functions in Multiple Sclerosis Based on Structural and Functional MR Imaging: Insights from a Multicenter Study.
Assessing the impact of multiple sclerosis disease activity and daclizumab HYP treatment on patient-reported outcomes: Results from the SELECT trial.
Interferon-β and serum 25-hydroxyvitamin D interact to modulate relapse risk in MS.
The AusD Study: A Population-based Study of the Determinants of Serum 25-Hydroxyvitamin D Concentration Across a Broad Latitude Range.
Prolonged-release fampridine and walking and balance in MS: randomised controlled MOBILE trial.
Male Sex Is Independently Associated with Faster Disability Accumulation in Relapse-Onset MS but Not in Primary Progressive MS.
Recurrent disease-activity rebound in a patient with multiple sclerosis after natalizumab discontinuations for pregnancy planning.
Microbial colonization influences early B-lineage development in the gut lamina propria.
1,25-Dihydroxyvitamin D3 acts directly on the T lymphocyte vitamin D receptor to inhibit experimental autoimmune encephalomyelitis.
Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial.
Delta-9-THC in the treatment of spasticity associated with multiple sclerosis.
Novartis receives European Commission approval for Gilenya®, the first oral multiple sclerosis treatment for use in the EU
A Study to Evaluate the Effectiveness, Tolerability and Safety of Laquinimod
Early signs of memory impairment among multiple sclerosis patients with clinically isolated syndrome.
Olive oil phenols and neuroprotection.
Phenytoin for neuroprotection in patients with acute optic neuritis: a randomised, placebo-controlled, phase 2 trial.
Response to "Glucocorticoids for treating Takotsubo syndrome?" and "Atypical global Takotsubo syndrome in a patient with acute disseminated encephalomyelitis".
Active, phosphorylated fingolimod inhibits histone deacetylases and facilitates fear extinction memory.
Diagnosis of exclusion: a case report of probable glatiramer acetate-induced eosinophilic myocarditis.

Pages